Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000176

Chief Medical Officer sold 3,743 shares at an average $13.81 ($51,684)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2025-08-12 Sale 10b5-1 −2,937 $13.58 $39,884 217,391 D
Ho Carole Chief Medical Officer 2025-08-13 Sale 10b5-1 −806 $14.64 $11,800 216,585 D
Open-market sales · 3,743 sh · avg $13.81 · $51,684
Loading xslF345X05/wk-form4_1755217980.xml…